Somerset Indus Capital Partners
Somerset Indus Capital Partners is a private equity firm based in India that focuses on leveraged buyouts, growth equity, and growth financing in privately held companies, particularly within the healthcare sector. The firm primarily targets middle-market companies involved in various aspects of healthcare delivery, including day care chains, budget hospitals, and specialized healthcare services such as ophthalmology and cardiology. It also invests in medical device manufacturing, diagnostics, and pharmaceutical companies, emphasizing market penetration and brand building. Additionally, Somerset explores retail models and patient delivery systems, including ambulatory services and rehabilitation facilities. The firm is led by Avinash Kenkare and Mayur Sirdesai, both seasoned professionals in private equity and the healthcare industry. Somerset typically invests around $5 million per portfolio company, aiming for controlling or influential minority stakes.
Globela Pharma
Private Equity Round in 2021
Globela Pharma is a pharmaceutical formulation manufacturing company that provides services to clients in various countries, including Bolivia, Costa Rica, Panama, Venezuela, Chile, Nigeria, Myanmar, Kenya, the Philippines, Sri Lanka, Ghana, Vietnam, and Ivory Coast. The company specializes in producing a range of medications, including general pharmacology products, oncology treatments, immunosuppressants, and cephalosporins. By adhering to global standards, Globela Pharma aims to deliver high-quality pharmaceutical products to meet the needs of its diverse clientele.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.